Prescribed injectable anti-aging kit containing six separate vials: glutathione, NAD+, L-carnitine, lysine, vitamin B-complex, and cyanocobalamin B12. Each vial targets a different dimension of cellular aging and is administered by intramuscular injection at home as directed by your provider.

Adults in anti-aging or longevity protocols who want comprehensive injectable nutritional and cellular support beyond what oral supplements deliver. It is particularly appropriate for patients already on hormone optimization, peptide therapy, or other anti-aging protocols who want to address the foundational cellular and metabolic layers simultaneously.

Yes. All six components are compounded prescription injectables requiring a valid prescription from a licensed provider before dispensing.

Oral glutathione is largely degraded in the GI tract before absorption. NAD+ is poorly absorbed orally at clinically meaningful doses. L-carnitine has limited intestinal absorption, particularly in older patients. Injectable delivery bypasses all GI barriers and achieves therapeutic plasma concentrations that oral supplements at standard doses cannot replicate.

Injection frequency for each vial is determined by your provider based on your protocol and goals. Most patients administer each vial once weekly or bi-weekly. NAD+ is typically dosed less frequently due to its smaller vial volume and concentrated dosing schedule.

No. Each vial is a separate injection administered on a schedule directed by your provider. Some vials may be injected on the same day while others are spaced across the week. Your provider will supply a specific schedule based on your protocol.

Energy improvements from B-complex, B12, and carnitine are often noticeable within the first 1-2 weeks. Skin brightening from glutathione typically develops over 6-8 weeks of consistent use. NAD+ and glutathione effects on recovery and mental clarity are generally reported within 2-4 weeks. Full anti-aging benefits accumulate over 3-6 months of consistent protocol adherence.

Injection site soreness, redness, or bruising is the most common effect and resolves within 24-48 hours. NAD+ administered too rapidly can cause flushing, nausea, or chest tightness. Glutathione is very well tolerated systemically. High-dose B12 may cause mild acne in sensitive individuals. Lysine at therapeutic injectable doses is generally very well tolerated.

Patients with known hypersensitivity to any ingredient should not use the affected vial. Patients receiving active chemotherapy should not use glutathione without clearance from their oncology team. Patients with kidney disease, pregnancy, breastfeeding, iron overload disorders, or complex medical conditions should disclose their full medical history before starting injectable amino acid therapy.

Yes. The stack is designed as a complementary protocol to hormone optimization and peptide therapy, addressing the cellular and nutritional foundations that maximize response to those therapies. Your provider will coordinate the full protocol.

Yes. Glutathione should be disclosed to an oncologist in patients receiving chemotherapy because antioxidant therapy may interfere with certain cancer treatment mechanisms. L-Carnitine may increase bleeding risk when combined with warfarin and may require INR monitoring. Patients should disclose all prescriptions, supplements, medical conditions, and active cancer treatment before starting therapy.

Patients with renal impairment should discuss L-carnitine and lysine use with their provider given renal excretion. Patients with hepatic disease may need glutathione dose adjustment. Patients on immunosuppressants should disclose all injectable supplements. Regular lab monitoring is recommended throughout any injection protocol.

Yes. All six components are appropriate for both men and women. Women who are pregnant or breastfeeding should consult their provider before starting any injectable protocol, as safety data for some components in pregnancy is limited.

Ecom Side Stack delivers the same therapeutic injectables at home via intramuscular injection rather than requiring clinic IV infusion visits. IM injection is clinically effective for all six components and significantly more convenient and cost-effective than recurring IV therapy sessions.